News
![DGAP-News: Knaus Tabbert AG: Knaus Tabbert achieves sales record despite supply shortages](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
DGAP-News: Knaus Tabbert AG: Knaus Tabbert achieves sales record despite supply shortages
DGAP-News: Knaus Tabbert AG: Knaus Tabbert achieves sales record despite supply shortages
![DGAP-News: Basler AG: Basler reports business figures for 2021 - company confirms strong annual result and gives growth outlook for 2022](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
DGAP-News: Basler AG: Basler reports business figures for 2021 - company confirms strong annual result and gives growth outlook for 2022
DGAP-News: Basler AG: Basler reports business figures for 2021 - company confirms strong annual result and gives growth outlook for 2022
![DGAP-News: Formycon is acquiring the biosimilar assets FYB201 and FYB202 and strengthening its position in the global growth market of biosimilars through long-term partnership with ATHOS KG](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
DGAP-News: Formycon is acquiring the biosimilar assets FYB201 and FYB202 and strengthening its position in the global growth market of biosimilars through long-term partnership with ATHOS KG
DGAP-News: Formycon is acquiring the biosimilar assets FYB201 and FYB202 and strengthening its position in the global growth market of biosimilars through long-term partnership with ATHOS KG
![Invitation to Oerlikon
Capital Markets Day
on May 17, 2022](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Invitation to Oerlikon Capital Markets Day on May 17, 2022
Invitation to Oerlikon
Capital Markets Day
on May 17, 2022
![Affluent Medical : 2021 full-year results and update on clinical programs.](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
Affluent Medical : 2021 full-year results and update on clinical programs.
Affluent Medical : 2021 full-year results and update on clinical programs.
![DGAP-Adhoc: Formycon and ATHOS KG merge development activities through the acquisition of biosimilar assets in a long-term strategic partnership](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
DGAP-Adhoc: Formycon and ATHOS KG merge development activities through the acquisition of biosimilar assets in a long-term strategic partnership
DGAP-Adhoc: Formycon and ATHOS KG merge development activities through the acquisition of biosimilar assets in a long-term strategic partnership
![Dalata Hotel Group PLC: Notice of AGM](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
Dalata Hotel Group PLC: Notice of AGM
Dalata Hotel Group PLC: Notice of AGM
![Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
![Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
![Form 8.3 - The Vanguard Group, Inc.: Pearson plc](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Form 8.3 - The Vanguard Group, Inc.: Pearson plc
Form 8.3 - The Vanguard Group, Inc.: Pearson plc
![Form 8.3 - The Vanguard Group, Inc.: National Express Group plc](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
![Form 8.3 - The Vanguard Group, Inc.: Meggitt plc](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
![Form 8.3 - The Vanguard Group, Inc.: HomeServe plc](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
![Designated Person Notification](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
Designated Person Notification
Designated Person Notification
![PAO Severstal: Update on the situation regarding the coupon payment for the Eurobond 2024](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
PAO Severstal: Update on the situation regarding the coupon payment for the Eurobond 2024
PAO Severstal: Update on the situation regarding the coupon payment for the Eurobond 2024
![Form 8.3 - The Vanguard Group, Inc.: GXO Logistics, Inc.](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Form 8.3 - The Vanguard Group, Inc.: GXO Logistics, Inc.
Form 8.3 - The Vanguard Group, Inc.: GXO Logistics, Inc.
![Form 8.3 - The Vanguard Group, Inc.: Avast plc](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
Form 8.3 - The Vanguard Group, Inc.: Avast plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
![Turkiye Garanti Bankasi A.S.: Issuance of debt instrument abroad under the Bank's Medium Term Note program](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Turkiye Garanti Bankasi A.S.: Issuance of debt instrument abroad under the Bank's Medium Term Note program
Turkiye Garanti Bankasi A.S.: Issuance of debt instrument abroad under the Bank's Medium Term Note program
![Chelverton UK Dividend Trust plc: Net Asset Value(s)](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
![DGAP-Adhoc: Preliminary Group result before taxes of DF Deutsche Forfait AG 2021 stronger than expected](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
DGAP-Adhoc: Preliminary Group result before taxes of DF Deutsche Forfait AG 2021 stronger than expected
DGAP-Adhoc: Preliminary Group result before taxes of DF Deutsche Forfait AG 2021 stronger than expected
![Travis Perkins: Director/PDMR Shareholding*](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
Travis Perkins: Director/PDMR Shareholding*
Travis Perkins: Director/PDMR Shareholding*
![Rights and Issues Investment Trust PLC: Net Asset Value(s)](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
![Hardman & Co Research: Q&A on ICG Enterprise Trust (ICGT): Spotlight on secondaries](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
Hardman & Co Research: Q&A on ICG Enterprise Trust (ICGT): Spotlight on secondaries
Hardman & Co Research: Q&A on ICG Enterprise Trust (ICGT): Spotlight on secondaries
![DGAP-News: Media and Games Invest SE: Sonja Lilienthal appointed new Chief Investment Officer to foster execution of MGI's M&A strategy](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
DGAP-News: Media and Games Invest SE: Sonja Lilienthal appointed new Chief Investment Officer to foster execution of MGI's M&A strategy
DGAP-News: Media and Games Invest SE: Sonja Lilienthal appointed new Chief Investment Officer to foster execution of MGI's M&A strategy
![Media and Games Invest SE: Sonja Lilienthal appointed new Chief Investment Officer to foster execution of MGI's M&A strategy](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Media and Games Invest SE: Sonja Lilienthal appointed new Chief Investment Officer to foster execution of MGI's M&A strategy
Media and Games Invest SE: Sonja Lilienthal appointed new Chief Investment Officer to foster execution of MGI's M&A strategy